Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Myofibroma × Laparoscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 14 Colonic Neoplasms 13 Stomach Neoplasms 10 Rectal Neoplasms 10 Ovarian Neoplasms 5 Neoplasms 5 Gastrointestinal Stromal Tumors 4 Carcinoma, Hepatocellular 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Endometrial Neoplasms 3 Neoplastic Cells, Circulating 2 Carcinoma, Renal Cell 2 Venous Thrombosis 1 Uterine Neoplasms 1 Surgical Wound Infection 1 Robotic 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Ornithine Carbamoyltransferase Deficiency Disease 1 Obesity, Morbid 1 Neurologic Manifestations 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Myofibroma 1 Malignant Neoplasm of Transverse Colon 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Locally Advanced Pancreatic Adenocarcinoma 1

Interventions

Uterine Myomectomy 3 Saline Solution 3 Misoprostol 3 Hysterectomy 3 dienogest 2 carbetocin 2 Tranexamic Acid 2 Tourniquets 2 Lidocaine 2 Hysteroscopy 2 Ascorbic Acid 2 remimazolam 1 relugolix 1 ramosetron 1 Vasopressins 1 Uterine Artery Embolization 1 Triptorelin Pamoate 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Respiration, Artificial 1 Remifentanil 1 Propofol 1 Population Groups 1 Observation 1 Nuclear Receptor Subfamily 4, Group A, Member 2 1 Morcellation 1 Methylergonovine 1 Laparoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06067971 2025-09-12

ENDORA2

University Hospital, Clermont-Ferrand

Phase NA Completed

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡